John Melki
Director and Chief Executive Officer
Microbiology
Genetic Signature
Australia
Biography
Dr Melki has led the commercialisation efforts of Genetic Signatures as Chief Executive Officer since 2011. Dr Melki originally joined Genetic Signatures in 2003 where he was responsible for leading the commercialisation of 2 research products (worldwide) and 5 diagnostic products (locally and Europe) in the role of Senior Principal Research Scientist. He has authored 20 peer-reviewed articles and is listed as an inventor on 8 patent applications. Dr Melki received his BSc from the University of New South Wales and his Ph.D. from the University of Sydney, where his thesis was awarded the Peter Bancroft Prize from the Medical School. His primary research focus for the last 20 years has been in the sodium bisulphite conversion of DNA which is at the core of Genetic Signatures’ technology.
Research Interest
Dr Melki originally joined Genetic Signatures in 2003 where he was responsible for leading the commercialisation of 2 research products (worldwide) and 5 diagnostic products (locally and Europe) in the role of Senior Principal Research Scientist. He has authored 20 peer-reviewed articles and is listed as an inventor on 8 patent applications. Dr Melki received his BSc from the University of New South Wales and his Ph.D. from the University of Sydney, where his thesis was awarded the Peter Bancroft Prize from the Medical School.
